IDVOther than small business
IDC (single-award IDV) SPE2DP20D0002TEVA PHARMACEUTICALS USA, INC.
Overview
Award facts
- Obligated on orders under this IDV
- $251.35M
- $251,353,632 across 523 orders
- Period of performance
- From Feb 3, 2020
- Modifications
- 8
- Latest action Dec 23, 2025
- Contract type
- IDC (single-award IDV)
- PIID SPE2DP20D0002
Description of requirement
4610052830!ADENOVIRUS TYPE 4 A
Dates and value
- Award date
- Signed on Feb 3, 2020
- Ordering period ends
- Dec 31, 2029
- Ceiling
- Ceiling (single-award vehicle): $420,486,475
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Jul 29, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 23, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationNORTH WALES, PA
UEINEN9A34LRHJ5
CAGE code3V8D7
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyTEVA PHARMACEUTICALS USA, INC.
Business types and certifications
Foreign-ownedFor-profit organizationCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Defense Logistics Agency
- DLA TROOP SUPPORT
- Funded by
- Department of Defense
- Defense Logistics Agency
- DLA TROOP SUPPORT
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Only one source-other (FAR 6.302-1 other)ONE
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- SPE2DP18R0113(as reported)
- Solicitation date
- Jan 9, 2019
Contract details
- Subcontracting plan
- Commercial subcontract planG
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Transaction history
Modification history
- Base award
- Feb 3, 2020
- Latest action
- Dec 23, 2025 — Option exercisedModification P00009
- Latest substantive action
- Dec 23, 2025 — Option exercisedModification P00009
- Actions by type
- Base award1
- Change order3
- Option exercised3
- Supplemental agreement (within scope)1
- Other administrative action1
Every modification
Each modification of this award, with its obligation change and reason.
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business incorporated in the U.S.C
- Sea transportation
- UnknownU
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / indefinite quantityB
- Multiple or single award
- Single awardS
- DoD claimant program
- Medical and dental supplies and equipmentC9B
- Awarding agency code
- 9700
- Awarding sub-tier code
- 97AS
- Contracting office code
- SPE2DP
- Transactions recorded under this award key
- 9
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 97AS
- Funding office code
- SPE2DP